Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)
China · Delayed Price · Currency is CNY 28.33
+1.36 (5.04%)
Sep 17, 2025, 2:45 PM CST
SHA:688319 Market Cap
SHA:688319 has a market cap or net worth of 11.40 billion as of September 17, 2025. Its market cap has increased by 229.19% in one year.
Market Cap
11.40B
Enterprise Value
11.60B
Revenue
668.43M
Ranking
n/a
PE Ratio
183.73
Stock Price
28.33
Market Cap Chart
Since June 8, 2021, SHA:688319's market cap has decreased from 16.17B to 11.40B, a decrease of -29.51%. That is a compound annual growth rate of -7.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 11.40B | 164.91% |
| Dec 31, 2024 | 4.30B | -32.95% |
| Dec 29, 2023 | 6.42B | 14.17% |
| Dec 30, 2022 | 5.62B | -61.27% |
| Dec 31, 2021 | 14.51B | -10.25% |
| Jun 8, 2021 | 16.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 460.12B |
| WuXi AppTec | 311.44B |
| Shenzhen Mindray Bio-Medical Electronics | 289.77B |
| Sichuan Biokin Pharmaceutical | 141.91B |
| Shanghai United Imaging Healthcare | 124.64B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.88B |
| Aier Eye Hospital Group | 119.82B |
| Yunnan Baiyao Group Co.,Ltd | 105.29B |